Eli Lilly Gets CDSCO Panel Nod To Import, Market Anti-cancer Drug Selpercatinib Dr. Divya Colin9 April 2024 6:00 PM ISTNew Delhi: Advising to conduct the Phase IV clinical trial, the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Anticancer drug: CDSCO panel seeks data for Eli Lilly Selpercatinib Dr. Nandita Mohan22 Feb 2023 5:30 PM ISTIn response to the drug major Eli Lilly's proposal to waive off Phase IV clinical trial in the country for the Selpercatinib 40 & 80mg capsules,...
Health Bulletin 22/February/2023 Dr. Nandita Mohan22 Feb 2023 4:19 PM ISTHere are the top health stories for the day:5 emergency seats at MGM Indore approved by NMCThe Medical Assessment and Rating Board (MARB) of National...
CDSCO panel seeks data for Eli Lilly's anticancer drug selpercatinib Dr. Divya Colin21 Feb 2023 6:00 PM ISTNew Delhi: In response to the drug major Eli Lilly's proposal to waive off Phase IV clinical trial in the country for the Selpercatinib 40 & 80mg...
Thermo Fisher Scientific bags USFDA nod for NGS-based CDx Test for lung, thyroid cancers Ruchika Sharma28 Sept 2022 12:45 PM ISTThe Oncomine Dx Target test is a next-generation sequencing (NGS)-based test that can detect multiple alterations at once from a small sample size,...
USFDA nod to Eli Lilly RET Inhibitor Retevmo for adults with advanced or metastatic solid tumors with a RET Gene Fusion, regardless of type Ruchika Sharma23 Sept 2022 4:20 PM ISTIn addition to the tumor-agnostic approval, the USFDA has granted traditional approval for Retevmo in adult patients with locally advanced or...
Eli Lilly Kinsale gets CDSCO panel nod to import, market anticancer drug Selpercatinib Dr. Divya Colin20 May 2022 5:52 PM ISTNew Delhi: Granting the clinical trial waiver, the Subject Expert Committee ( SEC) of the Central Drugs Standard Control Organization (CDSCO) has...
